• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANDA CORP PERCEVAL SUTURELESS AORTIC VALVE; TISSUE HEART VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANDA CORP PERCEVAL SUTURELESS AORTIC VALVE; TISSUE HEART VALVES Back to Search Results
Model Number PVS25
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Death (1802); Septic Shock (2068); Multiple Organ Failure (3261)
Event Date 05/09/2018
Event Type  Death  
Manufacturer Narrative
The manufacturing and material records for the perceval heart valve, model #icv1210 , s/n # (b)(4), as they pertain to the reported event, were retrieved and reviewed by quality engineering at livanova canada corp.The results confirmed that this valve satisfied all material, visual, and performance standards required for a (model #icv1210) perceval heart valve at the time of manufacture and release.Based on the information and reports received from the site, the device appeared to have a good functionality over time and prior to the event, with good mean gradients and no leaks.Given this, the event can reasonably be concluded as not device-related.Device location not presently known.
 
Event Description
The manufacturer was informed on the event through the (b)(6) registry.On (b)(6) 2016, the patient received a perceval pvs25 to replace his native, steno-insufficient aortic valve.The device was successfully implanted, with a transvalvular mean gradient of 7mmhg and no central/perivalvular leak.The conditions remained good at the 3 months follow up visit (5mmhg and no leaks) and at 1 year follow up visits (6mmhg and no leaks).On (b)(6) 2018, the patient was admitted to the hospital in septic shock and died on (b)(6) 2018 for multi-organ failure.On the day of the admission to the hospital, a tee was performed for further investigation on the event.There was no signs of mitral valve endocarditis, but a prosthetic valve endocarditis could not be excluded.Ct exam did not show any evidence of septic embolism.The surgeon started antibiotic treatment with ampicillin, flucloxacillin and gentamicin.(b)(6) was detected in the initially preserved blood cultures, which was more sensitive to the initiated antibiotic treatment.The patient had a wet gangrene of the left big toe, which was partially amputated on the same day.The patient's conditions continued to worsen up until (b)(6) 2018, when the patient died under good symptom control of his severe underlying disease.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC VALVE
Type of Device
TISSUE HEART VALVES
Manufacturer (Section D)
LIVANOVA CANDA CORP
5005 north fraser way
burnaby, british columbia V5J5M 1
CA  V5J5M1
Manufacturer (Section G)
LIVANOVA CANDA CORP
5005 north fraser way
burnaby, british columbia V5J5M 1
CA   V5J5M1
Manufacturer Contact
francesca crovato
5005 north fraser way
burnaby, british columbia V5J5M-1
CA   V5J5M1
MDR Report Key8057838
MDR Text Key126880920
Report Number3004478276-2018-00332
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000436
UDI-Public(01)00896208000436(240)ICV1210(17)200615
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,study
Reporter Occupation Physician
Type of Report Initial
Report Date 11/09/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/15/2020
Device Model NumberPVS25
Device Catalogue NumberICV1210
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 10/16/2018
Initial Date FDA Received11/09/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/15/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age80 YR
-
-